KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ORTHOPEDIATRICS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$22.03+0.08 (+0.36%)
Close on Oct 19, 2026
- Market cap
- $529.79M
- P/E (TTM)
- –
- Dividend yield
- –
ORTHOPEDIATRICS CORP revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scoliosis | $66.18M | $67.83M | $66.05M | $64.08M | $63.45M | $58.61M | $55.15M | $49.18M | $43.85M | $41.06M | $37.93M | $36.31M | 26.2% | +4.3% |
| Sports medicine/other | $4.09M | $4.00M | $4.00M | $3.26M | $3.71M | $4.15M | $4.45M | $4.71M | $4.28M | $4.08M | $4.02M | – | 1.6% | +10.4% |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $197.46M | $190.82M | $186.40M | $180.65M | $174.65M | $167.75M | $161.16M | $146.53M | $133.18M | $121.51M | $111.01M | $105.48M | 78.1% | +13.1% |
| International | $55.26M | $52.48M | $49.95M | $46.76M | $46.09M | $44.71M | $43.56M | $43.14M | $41.90M | $40.32M | $37.72M | $36.63M | 21.9% | +19.9% |
From the segment and revenue-disaggregation notes of Orthopediatrics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.